1. Home
  2. VOR

as 10-07-2025 1:59pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Founded: 2015 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 261.0M IPO Year: 2021
Target Price: $78.00 AVG Volume (30 days): 447.4K
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -342.66 EPS Growth: N/A
52 Week Low/High: $2.62 - $65.80 Next Earning Date: 11-06-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Stock Insider Trading Activity of Vor Biopharma Inc. (VOR)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Reprogrammed Interchange LLC VOR 10% Owner Sep 16 '25 Sell $1.54 447,278 $688,852.85 32,781,209
Reprogrammed Interchange LLC VOR 10% Owner Sep 15 '25 Sell $1.64 400,000 $656,320.00 32,781,209
Reprogrammed Interchange LLC VOR 10% Owner Sep 12 '25 Sell $1.75 300,000 $526,230.00 32,781,209
Reprogrammed Interchange LLC VOR 10% Owner Sep 11 '25 Sell $1.83 284,805 $521,420.99 32,781,209
Reprogrammed Interchange LLC VOR 10% Owner Sep 10 '25 Sell $1.82 350,000 $635,285.00 32,781,209
Reprogrammed Interchange LLC VOR 10% Owner Sep 9 '25 Sell $2.00 449,226 $898,631.69 32,781,209
Reprogrammed Interchange LLC VOR 10% Owner Sep 8 '25 Sell $1.99 464,421 $924,058.46 32,781,209
Reprogrammed Interchange LLC VOR N/A Aug 26 '25 Sell $2.08 284,190 $591,342.55 32,781,209
Reprogrammed Interchange LLC VOR N/A Aug 25 '25 Sell $2.12 387,346 $819,740.34 32,781,209

Share on Social Networks: